Panagora Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$143M Buy
1,385,308
+1,311,446
+1,776% +$117M 0.44% 39
2026
Q1
$5.3M Buy
73,862
+63,430
+608% +$4.89M 0.02% 400
2025
Q4
$828K Sell
10,432
-27,854
-73% -$2.2M ﹤0.01% 767
2025
Q3
$2.89M Sell
38,286
-1,078,456
-97% -$73.9M 0.01% 443
2025
Q2
$77M Buy
1,116,742
+1,076,509
+2,676% +$70.6M 0.35% 72
2025
Q1
$2.73M Buy
40,233
+29,660
+281% +$1.77M 0.01% 453
2024
Q4
$475K Sell
10,573
-12,895
-55% -$723K ﹤0.01% 851
2024
Q3
$1.48M Sell
23,468
-16,550
-41% -$966K 0.01% 605
2024
Q2
$2.36M Sell
40,018
-4,502
-10% -$282K 0.01% 476
2024
Q1
$3.55M Sell
44,520
-4,512
-9% -$345K 0.02% 407
2023
Q4
$3.87M Sell
49,032
-880,037
-95% -$62.6M 0.02% 375
2023
Q3
$64.9M Buy
929,069
+210,298
+29% +$14.9M 0.4% 65
2023
Q2
$49.7M Buy
718,771
+4,071
+0.6% +$290K 0.29% 92
2023
Q1
$53.1M Sell
714,700
-19,009
-3% -$1.59M 0.34% 77
2022
Q4
$68.4M Buy
733,709
+232,624
+46% +$22.4M 0.45% 54
2022
Q3
$47.8M Sell
501,085
-170,769
-25% -$16.9M 0.33% 77
2022
Q2
$62.3M Buy
671,854
+3,818
+0.6% +$373K 0.41% 54
2022
Q1
$67.6M Sell
668,036
-1,636
-0.2% -$172K 0.37% 64
2021
Q4
$69.1M Sell
669,672
-89,774
-12% -$8.3M 0.37% 58
2021
Q3
$64.4M Buy
759,446
+86,947
+13% +$7.28M 0.34% 65
2021
Q2
$56.1M Buy
672,499
+621,659
+1,223% +$50.9M 0.3% 71
2021
Q1
$3.83M Sell
50,840
-8,795
-15% -$641K 0.02% 537
2020
Q4
$4.07M Sell
59,635
-104,547
-64% -$6.8M 0.02% 478
2020
Q3
$9.59M Sell
164,182
-176,164
-52% -$11M 0.06% 254
2020
Q2
$22.1M Sell
340,346
-460,827
-58% -$29M 0.14% 146
2020
Q1
$47.5M Buy
801,173
+748,558
+1,423% +$50M 0.34% 75
2019
Q4
$3.91M Sell
52,615
-2,354
-4% -$165K 0.02% 559
2019
Q3
$3.47M Sell
54,969
-819
-1% -$48.5K 0.02% 566
2019
Q2
$3.04M Buy
55,788
+462
+0.8% +$24.9K 0.01% 661
2019
Q1
$2.98M Buy
55,326
+14,318
+35% +$884K 0.01% 688
2018
Q4
$2.69M Buy
41,008
+4,313
+12% +$322K 0.01% 666
2018
Q3
$2.89M Sell
36,695
-379,605
-91% -$27.1M 0.01% 712
2018
Q2
$26.8M Sell
416,300
-975,634
-70% -$64.3M 0.11% 189
2018
Q1
$86.6M Sell
1,391,934
-727,525
-34% -$52.2M 0.34% 78
2017
Q4
$154M Buy
2,119,459
+274,049
+15% +$19.9M 0.58% 34
2017
Q3
$150M Sell
1,845,410
-375,277
-17% -$29.7M 0.59% 29
2017
Q2
$179M Buy
2,220,687
+213,897
+11% +$16.9M 0.72% 22
2017
Q1
$158M Buy
2,006,790
+748,559
+59% +$59.8M 0.66% 24
2016
Q4
$99.3M Buy
1,258,231
+274,761
+28% +$22.2M 0.45% 41
2016
Q3
$87.5M Sell
983,470
-140,242
-12% -$13.2M 0.42% 53
2016
Q2
$108M Sell
1,123,712
-115,015
-9% -$11.5M 0.53% 38
2016
Q1
$128M Sell
1,238,727
-583,143
-32% -$56.7M 0.64% 24
2015
Q4
$178M Sell
1,821,870
-5,171
-0.3% -$506K 0.88% 15
2015
Q3
$176M Buy
1,827,041
+278,680
+18% +$29.3M 0.93% 13
2015
Q2
$162M Buy
1,548,361
+55,488
+4% +$5.67M 0.81% 18
2015
Q1
$154M Sell
1,492,873
-139,530
-9% -$14.1M 0.78% 13
2014
Q4
$157M Sell
1,632,403
-176,213
-10% -$15.5M 0.8% 18
2014
Q3
$144M Buy
1,808,616
+408,925
+29% +$32.2M 0.7% 26
2014
Q2
$105M Sell
1,399,691
-144,701
-9% -$10.9M 0.51% 45
2014
Q1
$116M Sell
1,544,392
-380,363
-20% -$26.9M 0.55% 37
2013
Q4
$138M Sell
1,924,755
-1,070,685
-36% -$68.8M 0.64% 32
2013
Q3
$170M Buy
2,995,440
+882,459
+42% +$52.6M 0.84% 23
2013
Q2
$121M Buy
+2,112,981
New +$122M 0.62% 37

Other funds holding CVS

Panagora Asset Management's CVS Position: Q2 2026 in Review

Panagora Asset Management increased its CVS Health (CVS) stake by 1,776% in Q2 2026, buying an estimated $117M and bringing the position to 1,385,308 shares worth $143M. The position accounts for 0.44% of the portfolio, ranked #39.

Panagora Asset Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $179M in Q2 2017. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Panagora Asset Management held 1,385,308 shares of CVS Health worth $143M as of Q2 2026.
  • Panagora Asset Management bought 1,311,446 CVS Health shares in Q2 2026, an estimated $117M.
  • CVS Health made up 0.44% of Panagora Asset Management's portfolio in Q2 2026, its #39 holding.
  • Panagora Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Panagora Asset Management's CVS Health position peaked at $179M in Q2 2017.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.